Researchers have been successful in increasing HIV treatment success rates by almost 18 percent.
Teams from the Universities of Aberdeen, Maastricht and the University and Academic Medical Centre in Amsterdam, developed a new programme designed to better assist patients treated for HIV in taking their ...
University of Alabama at Birmingham School of Nursing Professor David Vance, Ph.D., has received a two-year, $404,250 R21 grant from the National Institute of Nursing Research for his project “Individualized-Targeted Training in Older Adults with HAND” to develop cognitive training interventions to improve everyday functioning ...
2 March 2017 – Today marks a significant development in responding to the HIV testing gap with the approval of the first product for HIV self-testing (HIVST) by the UNITAID-funded Expedited Review Panel for Diagnostics (ERPD), hosted by the Global Fund to Fight AIDS, Tuberculosis ...
More research is needed into how the virus may affect cerebral small vessel disease, a leading cause of cognitive decline.
Even when people with HIV are doing well on antiretroviral (ARV) treatment, they are apparently more likely to have certain abnormalities in blood vessels in the ...
SEATTLE — Assessing multiple viral load (VL) values across time may better inform treatment response and potential for HIV transmission, according to researchers at the Centers for Disease Control and Prevention (CDC). They presented new data at the Conference on Retroviruses and Opportunistic Infections (CROI ...
Monash University and Cardiff University (UK) researchers have come a step further in understanding how the human immunodeficiency virus (HIV) evades the immune system.
Declared a pandemic in 1987 by the World Health Organization, HIV infection has been responsible for 39 million deaths over the last ...
Close to 60% of adults benefiting from point-of-care CD4 cell count testing at HIV testing sites, accelerated antiretroviral (ART) initiation and SMS appointment reminders were retained in care after one year, compared to just 44% of those receiving the standard of care (SOC) in Mozambique, ...
SEATTLE — Integration of ART into maternal and child health services during the postnatal period leads to significant improvements in women’s participation in HIV care and resulting viral suppression, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI).
“To understand the context ...
Research on the continuum of HIV care must be improved and benchmarked against an integrated, comprehensive framework in order to make strides against the HIV epidemic, according to researchers at the Rollins School of Public Health, Johns Hopkins University, and the Centers for Disease Control ...
SEATTLE — Data from a study of HIV–infected infants who received early ART suggest the reservoir for HIV lies in cells that were infected before ART initiation.
“This is important because we have to understand what the reservoir is to be able to target it and ...
Bictegravir, an investigational integrase inhibitor from Gilead Sciences, was highly potent, well tolerated and worked as well as dolutegravir (Tivcay) in a phase 2 clinical trial, according to study results presented on Tuesday at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle ...
Longer time living with diagnosed HIV infection is strongly associated with depression, anxiety and poor quality of life, according to UK research published in HIV Medicine. Older age in itself was not associated with symptoms of distress or poor mental health but did have an ...
Access to sexual health services among gay and bisexual men worldwide is still essential
MSMGF (the Global Forum on MSM & HIV) endorses the Consensus Statement on Risk of Sexual Transmission of HIV from a Person Living with HIV Who Has an Undetectable Viral Load. That ...
Growing up in eastern Ukraine, Svitlana Moroz said she was a typically reckless teenager who believed she’d live forever.
She shared needles with friends to inject opium, had unprotected sex with a guy her own age, and five months after hooking up with him, learned she ...
Bioquark Inc. and SC21 Biotech are collaborating on novel cellular therapies for long term HIV control by cost effectively and industrially scaling the production of HIV resistant cells for allogeneic transplant needs.
Phialdelphia, PA, February 11, 2017 – Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused ...
New Rochelle, NY, February 9, 2017—A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The third annual ...
Last June, a Perspective piece in the New England Journal of Medicine noted the critical place that the World Health Organization’s list of Essential Medicines had assumed in global health policy and responses — donors, governments and insurers were all more likely to invest in ...
Following individuals through the cascade of care, from HIV diagnosis to treatment and undetectable viral load, rather than taking snapshots of performance, has led researchers on a major South African study to pinpoint linkage to care after testing HIV positive as the biggest weakness of ...